CRT 2026

Medical Therapy and Revascularization for Asymptomatic Carotid Stenosis | Results of the CREST-2 Trial

Speaker(s)

• GR

  Gary Roubin, MD

  Chair CREST2 Trial Interventional Management Committee

  Disclosure information not submitted.